粉防己碱对肺动脉高压大鼠中NLRP3炎性小体表达研究

刘莹; 董文鹏; 陈长富; 杨永超; 杨东鹏; 王晓武

doi:10.13201/j.issn.1001-1439.2017.11.019

粉防己碱对肺动脉高压大鼠中NLRP3炎性小体表达研究

- 1 广州中医药大学(广州, 510010);
- 2 广州军区广州总医院心血管外科中心(广州, 510010);
- 3 广东省人民医院心血管病研究所;
- 4 广州市红十字会医院心血管外科
基金项目:
广东省自然科学基金 (No:2015A03031362)

国家自然科学基金 (No:81500298)

广州市珠江科技新星专项基金 (No:201610010094)

详细信息

通讯作者: 王晓武, E-mail:xzwk_wxw@hotmail.com

中图分类号: R54

收稿日期: 2017-06-12

Impact of the NLRP3 inflammasome on tetrandrine in rats with pulmonary arterial hypertension

- 1 Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510010, China;
- 2 Department of Cardiovascular Surgery, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong, 510010, China;
- 3 Institue of Cardiovascular Disease, Guangdong People's Hospital;
- 4 Department of Cardiovascular Surgery, Guangzhou Red Cross Hospital

More Information

Corresponding author: WANG Xiaowu, E-mail: xzwk_wxw@hotmail.com

Received Date: 12 June 2017

摘要

摘要: 目的:研究肺动脉高压大鼠中NLRP3炎性小体的表达情况, 探究粉防己碱对肺动脉高压的保护作用。方法:36只雄性SD大鼠, 随机分为3组:正常对照组 (control)、肺动脉高压组 (MCT)、粉防己碱组 (Tet)。对照组单剂量给予0.9%氯化钠腹腔注射, 其余两组单剂量给予野百合碱腹腔注射后正常饲养21d;而后Tet组每天给予粉防己碱药物灌胃, 其余两组则每天给予0.9%氯化钠灌胃21d后留取组织标本, 测量肺动脉压力 (右室收缩压, right ventricular systolic pressure, RVSP), 计算右心室/(左心室+心室壁)[RV/(LV+S)]比值, 行HE染色观测各组形态学变化, 免疫组化及western blot检测各组NLRP3、caspase-1及白细胞介素-1β (IL-1β) 的表达水平。结果:①与对照组相比, MCT及Tet组RVSP、RV/(LV+S) 值均明显增高 (P<0.05);与MCT组相比, Tet组又明显下降 (P<0.05)。②病理组织学检测结果显示, 粉防己碱可减轻PAH模型大鼠肺小动脉内膜增生, 减少肺组织炎性细胞浸润; ③免疫组化及western blot结果显示, 粉防己碱可抑制NLRP3、caspase-1、IL-1β的表达。结论:粉防己碱可以抑制NLRP3炎性小体的活化, 减轻肺动脉高压大鼠肺组织的炎性浸润, 对肺动脉高压具有一定的逆转作用。
- 肺动脉高压 /
- 粉防己碱 /
- 炎性小体
Abstract: Objective:To investigate expression of the NLRP3 inflammasome in pulmonary arterial hypertension rats and explore the protective effect of tetrandrine on pulmonary arterial hypertension.Method:A toll of 36 male Sprague-Dawley (SD) rats were randomly and equally devided into 3 groups:control group, MCT group and Tet group.The control group was given intraperitoneal injection with normal saline;the others were given intraperitoneal injection with monocrotaline (MCT) to induce PAH, then given irrigation with saline and tetrandrine respectively, from day 21 to day 42.Right ventricular systolic pressure (RVSP), right ventricular hypertrophy index (RV/(LV+S)) were measured and compared among all groups.HE staining was used to observe the morphological changes of each group.Expression of NLRP3, caspase-1 and IL-1βwere detected by immunohistochemistry and western blot.Result:①Compared with control group, RVSP and RV/(LV + S) were significantly increased in MCT and Tet groups (P<0.05);While compared with MCT group, Tet group was significantly decreased (P<0.05). ②Histopathological examination showed that Tet could reduce the pulmonary arterial hyperplasia of PAH rats and reduce the infiltration of inflammatory cells in lung tissue.③Resultsof immunohistochemistry and western blot showed that Tet reduced the expression of NLRP3, caspase-1 and IL-1β.Conclusion:Tetrandrine could inhibit the activation of NLRP3 inflammasome, reduce the inflammatory infiltration of lung tissue in pulmonary hypertension rats, and have a certain reversal effect on pulmonary hypertension.
- pulmonary arterial hypertension /
- tetrandrine /
- inflammasome

HTML全文

参考文献(15)

[1]	DE JESUS PEREZ VINICIO A.Molecular pathogenesis and current pathology of pulmonary hypertension[J].Heart Fail Rev, 2016, 21:239-257.
[2]	TSCHOPP J, SCHRODER K.NLRP3 inflammasome activation:the convergence of multiple signalling pathways on ROS production?[J].Nat Rev Immunol, 2010, 10:210-215.
[3]	DOLINAY T, KIM Y S, HOWRYLAK J, et al.Inflammasome-regulated cytokines are critical mediators of acute lung injury[J].Am J Respir Crit Care Med, 2015, 185:1225-1234.
[4]	WANG X W, YANG Y C, YANG D P, et al.Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1[J].Journal of Vascular Surgery, 2015, DOI:http://dx.doi.org/10.1016/j.jvs.2015.09.016.
[5]	陈晓辉, 翁国星, 林群.一种新型的大鼠肺动脉高压模型[J].中华实验外科杂志, 2005, 22 (8):882-885.
[6]	TUDER R M.Pulmonary vascular remodeling in pulmonary hypertension[J].Cell Tissue Res, 2016, 32:112-115.
[7]	LEE M Y, TSAI K B, HSU J H, et al.Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1and enhancing eNOS/sGC/PKG pathways[J].Sci Rep, 2016, 6:31788-31789.
[8]	MOUDGIL R, MICHELAKIS E D, ARCHER S L.The role of K+channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis:implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension[J].Microcirculation, 2006, 13:615-632.
[9]	VENGETHASAMY L, HAUTEFORT A, TIELEMANS B, et al.BMPRⅡinfluences the response of pulmonary microvascular endothelial cells to inflammatory mediators[J].Pflugers Arch, 2016, 33:155-156.
[10]	MARLENE R, CHRISTOPHE G, MARC H, et al.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension[J].Circ Res, 2014, 115:165-175.
[11]	PETRILLI V, DOSTERT C, MURUVE D A, et al.The inflammasome:a danger sensing complex triggering innate immunity[J].Curr Opin Immunol, 2007, 19:615-622.
[12]	FRANCHI L, EIGENBROD T, MUNOZ-PLANILLO R, et al.The inflammasome:a caspase-1-activation platform that regulates immune responses and disease pathogenesis[J].Nat Immunol, 2009, 10:241-247.
[13]	BERGSBAKEN T, FINK S L, COOKSON B T.Pyroptosis:host cell death and inflammation[J].Nat Rev Microbiol, 2009, 7:99-109.
[14]	LIU Q Y, KARPINSKI E, PANG P K.Tetrandrine inhibits both T and L calcium channel currents in ventricular cells[J].J Cardiovasc Pharmacol, 1992, 20:513-519.
[15]	LIU M H, XIE W R, ZHANG Z, et al.Inhibitive effect of tetrandrine on the proliferation of diabetes mellitus rats vascular smooth muscle cells[J].Zhong Yao Cai, 2009, 32:1867-1870.